tiprankstipranks
Advertisement
Advertisement

PCPROMI Stock Latest News

Promise Bio Showcases Scientific Leadership and AI-Driven IBD Platform in Busy Week
Private CompaniesPromise Bio Showcases Scientific Leadership and AI-Driven IBD Platform in Busy Week
11d ago
PROMI
Scientific Leadership Recognition Highlights Promise Bio’s Research Profile
PremiumPrivate Companies
Scientific Leadership Recognition Highlights Promise Bio’s Research Profile
12d ago
PROMI
External Scientific Recognitions Highlight Leadership Strength at Promise Bio
PremiumPrivate Companies
External Scientific Recognitions Highlight Leadership Strength at Promise Bio
13d ago
PROMI
Promise Bio Highlights AI-Driven Precision Medicine Platform for IBD at DDW
PremiumPrivate Companies
Promise Bio Highlights AI-Driven Precision Medicine Platform for IBD at DDW
14d ago
PROMI
Promise Bio Targets IBD Partnerships With Precision-Medicine Platform
PremiumPrivate Companies
Promise Bio Targets IBD Partnerships With Precision-Medicine Platform
14d ago
PROMI
Promise Bio Highlights Strategy to Tackle Ground-Truth Challenges in Functional Proteomics
PremiumPrivate CompaniesPromise Bio Highlights Strategy to Tackle Ground-Truth Challenges in Functional Proteomics
21d ago
PROMI
Promise Bio Targets Ground-Truth Challenges in Functional Proteomics
Premium
Private Companies
Promise Bio Targets Ground-Truth Challenges in Functional Proteomics
21d ago
PROMI
Promise Bio Emphasizes Proteoform-Focused Approach to Advance Functional Proteomics
Premium
Private Companies
Promise Bio Emphasizes Proteoform-Focused Approach to Advance Functional Proteomics
2M ago
PROMI
Promise Bio Highlights Functional Proteomics Focus With Emphasis on Proteoforms and PTMs
PremiumPrivate Companies
Promise Bio Highlights Functional Proteomics Focus With Emphasis on Proteoforms and PTMs
2M ago
PROMI
Promise Bio Advances AI-Driven Epiproteomics Strategy and Targets New Partnerships
PremiumPrivate Companies
Promise Bio Advances AI-Driven Epiproteomics Strategy and Targets New Partnerships
2M ago
PROMI
Promise Bio Highlights AI-Enabled Epiproteomics Focus in Immunology
PremiumPrivate Companies
Promise Bio Highlights AI-Enabled Epiproteomics Focus in Immunology
2M ago
PROMI
Promise Bio Highlights Epiproteomics and AI Approach in Precision Medicine
PremiumPrivate Companies
Promise Bio Highlights Epiproteomics and AI Approach in Precision Medicine
2M ago
PROMI
Promise Bio Targets Partnerships With AI-Driven IBD Precision Medicine Platform
PremiumPrivate CompaniesPromise Bio Targets Partnerships With AI-Driven IBD Precision Medicine Platform
2M ago
PROMI
Promise Bio Targets Partnerships at Precision Medicine IBD Summit
Premium
Private Companies
Promise Bio Targets Partnerships at Precision Medicine IBD Summit
2M ago
PROMI
Promise Bio Launches Epiproteomic Grant Targeting Biotech Drug Development
Premium
Private Companies
Promise Bio Launches Epiproteomic Grant Targeting Biotech Drug Development
2M ago
PROMI
Promise Bio Promotes Epiproteomic Grant to Deepen Proteomics Adoption
PremiumPrivate Companies
Promise Bio Promotes Epiproteomic Grant to Deepen Proteomics Adoption
2M ago
PROMI
Promise Bio Targets Biotech Adoption With New Epiproteomic Grant and Biomarker Push
PremiumPrivate Companies
Promise Bio Targets Biotech Adoption With New Epiproteomic Grant and Biomarker Push
2M ago
PROMI
Promise Bio Launches Grant Program to Promote Epiproteomic Drug Development
PremiumPrivate Companies
Promise Bio Launches Grant Program to Promote Epiproteomic Drug Development
2M ago
PROMI
Promise Bio Launches Epiproteomic Innovation Grant Targeting Drug Developers
PremiumPrivate Companies
Promise Bio Launches Epiproteomic Innovation Grant Targeting Drug Developers
2M ago
PROMI
Promise Bio Launches Grant Program to Expand Adoption of Epiproteomic Drug Development Tools
PremiumPrivate CompaniesPromise Bio Launches Grant Program to Expand Adoption of Epiproteomic Drug Development Tools
2M ago
PROMI
Promise Bio Launches Grant Program to Advance Epiproteomic Drug Development Insights
Premium
Private Companies
Promise Bio Launches Grant Program to Advance Epiproteomic Drug Development Insights
2M ago
PROMI
Promise Bio Launches Grant Program to Expand Access to Epiproteomic Drug R&D Insights
Premium
Private Companies
Promise Bio Launches Grant Program to Expand Access to Epiproteomic Drug R&D Insights
2M ago
PROMI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >